Skip to main content

Table 3 Incidence of hematologic AEs classified by SOC and PT based on gender

From: Alvopem® (pemetrexed) safety assessment in patients with non-small cell lung cancer or malignant pleural mesothelioma: a post-marketing surveillance

System organ class

Preferred term

Male

N (%)

Female

N (%)

Blood and lymphatic system disorders

Anemia

121 (93.07)

57 (83.82)

Leukopenia

29 (22.31)

20 (29.42)

Neutropenia

32 (24.61)

26 (38.24)

Thrombocytopenia

13 (10)

7 (10.29)